DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
Authors
Keywords
DNA vaccination, Antibodies, Recombinant vaccines, Recombinant proteins, Schistosoma mansoni, Cytokines, Enzyme-linked immunoassays, Schistosomiasis
Journal
PLoS One
Volume 10, Issue 5, Pages e0125075
Publisher
Public Library of Science (PLoS)
Online
2015-05-06
DOI
10.1371/journal.pone.0125075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Solution Structure, Membrane Interactions, and Protein Binding Partners of the Tetraspanin Sm-TSP-2, a Vaccine Antigen from the Human Blood FlukeSchistosoma mansoni
- (2014) Xinying Jia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2
- (2012) Mark S. Pearson et al. PLoS Neglected Tropical Diseases
- Immunization with rP22 induces protective immunity against Schistosoma mansoni: Effects on granuloma down-modulation and cytokine production
- (2011) Cíntia M.F. Rezende et al. IMMUNOLOGY LETTERS
- Computational Vaccinology: An Important Strategy to Discover New PotentialS. mansoniVaccine Candidates
- (2011) Carina S. Pinheiro et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Enzymatic Shaving of the Tegument Surface of Live Schistosomes for Proteomic Analysis: A Rational Approach to Select Vaccine Candidates
- (2011) William Castro-Borges et al. PLoS Neglected Tropical Diseases
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- DNA Vaccines: Developing New Strategies against Cancer
- (2010) Daniela Fioretti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Schistosoma mansoni Stomatin Like Protein-2 Is Located in the Tegument and Induces Partial Protection against Challenge Infection
- (2010) Leonardo P. Farias et al. PLoS Neglected Tropical Diseases
- Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection withSchistosoma mansoniin mouse
- (2009) W. ZHANG et al. PARASITE IMMUNOLOGY
- Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine
- (2008) Mahmoud H Romeih et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Recent advances in vaccine research against schistosomiasis in Brazil
- (2008) Sergio C. Oliveira et al. ACTA TROPICA
- Current Status of Vaccines for Schistosomiasis
- (2008) D. P. McManus et al. CLINICAL MICROBIOLOGY REVIEWS
- Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni
- (2008) G. AHMAD et al. PARASITE IMMUNOLOGY
- The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
- (2008) Shixia Wang et al. VACCINE
- Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection
- (2008) Fernanda C. Cardoso et al. PLoS Neglected Tropical Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started